Nisha Acharya

Nisha Acharya

scientistFemale0.0Global Dominance: 0.00%

Dr. Nisha Acharya is a clinician scientist and ophthalmologist at the University of California, San Francisco, specializing in inflammatory diseases of the eye. Her research focuses on the safety and effectiveness of vaccines, particularly the shingles vaccine, which is recommended for adults aged 50 and older. Recently, she made headlines when the National Institutes of Health terminated her grant, which was aimed at studying the risks and benefits of the shingles vaccine, amid a broader policy shift under the leadership of Robert F. Kennedy Jr. at the Department of Health and Human Services. Despite not studying vaccine hesitancy, her funding was caught in a wave of cancellations affecting researchers exploring vaccination issues, which she argues undermines vital safety research in the field.

Power0
Reach0
Collect

Not in the pool (under ¢1).

Recent news mentions

Nisha Acharya's research funding was abruptly stopped due to political reasons.

Trump stoppt Forschungsgelder – Forscher in der Krise – NZZ Akzent
Neue Zürcher Zeitung·SwitzerlandSwitzerland· 2025-04-23
5.0

Nisha Acharya is a researcher at the University of California, San Francisco, studying infectious diseases and has recently lost funding due to her use of the words 'vaccination' and 'skepticism' in a grant application.

Trump-Regierung streicht Forschungsbudgets: Flucht nach Europa
Neue Zürcher Zeitung·SwitzerlandSwitzerland· 2025-04-11
5.0

Dr. Nisha Acharya's grant to study the safety and effectiveness of a vaccine was terminated by the NIH.

Her research revealed a safety concern with a vaccine. Then the NIH pulled her funding
CNN·United StatesUnited States· 2025-03-28
5.0